MCI Onehealth Technologies Inc.

DRDR.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRDR.TO stands at 49.4M. In comparison, SIA.TO has a market cap of 1.7B. Regarding current trading prices, DRDR.TO is priced at CA$0.55, while SIA.TO trades at CA$18.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRDR.TO currently has a P/E ratio of -0.83, whereas SIA.TO's P/E ratio is 45.29. In terms of profitability, DRDR.TO's ROE is -1.02%, compared to SIA.TO's ROE of +0.07%. Regarding short-term risk, DRDR.TO is more volatile compared to SIA.TO. This indicates potentially higher risk in terms of short-term price fluctuations for DRDR.TO.

DRDR.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRDR.TO stands at 49.4M. In comparison, DNTL.TO has a market cap of 1.6B. Regarding current trading prices, DRDR.TO is priced at CA$0.55, while DNTL.TO trades at CA$8.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRDR.TO currently has a P/E ratio of -0.83, whereas DNTL.TO's P/E ratio is -28.47. In terms of profitability, DRDR.TO's ROE is -1.02%, compared to DNTL.TO's ROE of -0.03%. Regarding short-term risk, DRDR.TO is more volatile compared to DNTL.TO. This indicates potentially higher risk in terms of short-term price fluctuations for DRDR.TO.

DRDR.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRDR.TO stands at 49.4M. In comparison, EXE.TO has a market cap of 1.2B. Regarding current trading prices, DRDR.TO is priced at CA$0.55, while EXE.TO trades at CA$14.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRDR.TO currently has a P/E ratio of -0.83, whereas EXE.TO's P/E ratio is 16.30. In terms of profitability, DRDR.TO's ROE is -1.02%, compared to EXE.TO's ROE of +0.66%. Regarding short-term risk, DRDR.TO is more volatile compared to EXE.TO. This indicates potentially higher risk in terms of short-term price fluctuations for DRDR.TO.

DRDR.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRDR.TO stands at 49.4M. In comparison, WELL.TO has a market cap of 1B. Regarding current trading prices, DRDR.TO is priced at CA$0.55, while WELL.TO trades at CA$4.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRDR.TO currently has a P/E ratio of -0.83, whereas WELL.TO's P/E ratio is -36.73. In terms of profitability, DRDR.TO's ROE is -1.02%, compared to WELL.TO's ROE of -0.03%. Regarding short-term risk, DRDR.TO is more volatile compared to WELL.TO. This indicates potentially higher risk in terms of short-term price fluctuations for DRDR.TO.

DRDR.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRDR.TO stands at 49.4M. In comparison, DR.TO has a market cap of 296.9M. Regarding current trading prices, DRDR.TO is priced at CA$0.55, while DR.TO trades at CA$15.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRDR.TO currently has a P/E ratio of -0.83, whereas DR.TO's P/E ratio is 7.32. In terms of profitability, DRDR.TO's ROE is -1.02%, compared to DR.TO's ROE of +0.84%. Regarding short-term risk, DRDR.TO is more volatile compared to DR.TO. This indicates potentially higher risk in terms of short-term price fluctuations for DRDR.TO.

DRDR.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRDR.TO stands at 49.4M. In comparison, CRRX.TO has a market cap of 178.3M. Regarding current trading prices, DRDR.TO is priced at CA$0.55, while CRRX.TO trades at CA$2.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRDR.TO currently has a P/E ratio of -0.83, whereas CRRX.TO's P/E ratio is -47.17. In terms of profitability, DRDR.TO's ROE is -1.02%, compared to CRRX.TO's ROE of -0.05%. Regarding short-term risk, DRDR.TO is more volatile compared to CRRX.TO. This indicates potentially higher risk in terms of short-term price fluctuations for DRDR.TO.

DRDR.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRDR.TO stands at 49.4M. In comparison, GTMS.TO has a market cap of 28.6M. Regarding current trading prices, DRDR.TO is priced at CA$0.55, while GTMS.TO trades at CA$0.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRDR.TO currently has a P/E ratio of -0.83, whereas GTMS.TO's P/E ratio is -0.45. In terms of profitability, DRDR.TO's ROE is -1.02%, compared to GTMS.TO's ROE of +15.74%. Regarding short-term risk, DRDR.TO is less volatile compared to GTMS.TO. This indicates potentially lower risk in terms of short-term price fluctuations for DRDR.TO.

DRDR.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRDR.TO stands at 49.4M. In comparison, NUMI.TO has a market cap of 16.3M. Regarding current trading prices, DRDR.TO is priced at CA$0.55, while NUMI.TO trades at CA$0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRDR.TO currently has a P/E ratio of -0.83, whereas NUMI.TO's P/E ratio is -0.63. In terms of profitability, DRDR.TO's ROE is -1.02%, compared to NUMI.TO's ROE of -1.95%. Regarding short-term risk, DRDR.TO is more volatile compared to NUMI.TO. This indicates potentially higher risk in terms of short-term price fluctuations for DRDR.TO.

DRDR.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRDR.TO stands at 49.4M. In comparison, EPW.CN has a market cap of 4.1M. Regarding current trading prices, DRDR.TO is priced at CA$0.55, while EPW.CN trades at CA$0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRDR.TO currently has a P/E ratio of -0.83, whereas EPW.CN's P/E ratio is -0.27. In terms of profitability, DRDR.TO's ROE is -1.02%, compared to EPW.CN's ROE of +0.47%. Regarding short-term risk, DRDR.TO is more volatile compared to EPW.CN. This indicates potentially higher risk in terms of short-term price fluctuations for DRDR.TO.

DRDR.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRDR.TO stands at 49.4M. In comparison, OMIC.CN has a market cap of 2.3M. Regarding current trading prices, DRDR.TO is priced at CA$0.55, while OMIC.CN trades at CA$0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRDR.TO currently has a P/E ratio of -0.83, whereas OMIC.CN's P/E ratio is -4.50. In terms of profitability, DRDR.TO's ROE is -1.02%, compared to OMIC.CN's ROE of -0.83%. Regarding short-term risk, DRDR.TO is more volatile compared to OMIC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for DRDR.TO.

DRDR.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRDR.TO stands at 49.4M. In comparison, CALM.CN has a market cap of 1.4M. Regarding current trading prices, DRDR.TO is priced at CA$0.55, while CALM.CN trades at CA$0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRDR.TO currently has a P/E ratio of -0.83, whereas CALM.CN's P/E ratio is -0.11. In terms of profitability, DRDR.TO's ROE is -1.02%, compared to CALM.CN's ROE of +3.14%. Regarding short-term risk, DRDR.TO is more volatile compared to CALM.CN. This indicates potentially higher risk in terms of short-term price fluctuations for DRDR.TO.

DRDR.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRDR.TO stands at 49.4M. In comparison, MEDI.NE has a market cap of 17.8K. Regarding current trading prices, DRDR.TO is priced at CA$0.55, while MEDI.NE trades at CA$0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRDR.TO currently has a P/E ratio of -0.83, whereas MEDI.NE's P/E ratio is -0.02. In terms of profitability, DRDR.TO's ROE is -1.02%, compared to MEDI.NE's ROE of N/A. Regarding short-term risk, DRDR.TO is less volatile compared to MEDI.NE. This indicates potentially lower risk in terms of short-term price fluctuations for DRDR.TO.